retatrutide news today recency 3 just took a major step toward FDA approval, and the numbers are unlike anything we've seen from a weight-loss injection. In Eli Lilly's phase TRIUMPH-1 trial, participants on the highest Retatrutide: FDA approval time, trial

Many people underestimate appetite suppression until they compare their starting behavior to what emerges after treatment begins

GLP-1 drugs and gut-brain depression link We've been talking about GLP-1 drugs (Ozempic, Wegovy, Mounjaro) for weight loss and diabetes for years

Given the immunosuppressive features of cannabis smoke on lung macrophages, a similar response could occur, although more research is needed to understand the impact of cannabis smoke and cannabinoids on macrophage efferocytosis and whether such changes are beneficial or detrimental

Weight Loss Coverage Has Flatlined and Some Employers Are Cutting It Employer coverage of GLP-1s for weight loss sat at 36% in both 2025 and 2026 , after climbing from 26% in 2023

For clients, the death of a judge might spread uncertainty about their cases

One new near-term risk to growth could be inflationary pressures, since a large percentage of GLP-1 sales are driven by out-of-pocket payments, Flynn says